Agenus, Inc. (AGEN)
3.12
-0.04
(-1.27%)
USD |
NASDAQ |
May 22, 16:00
3.12
0.00 (0.00%)
After-Hours: 20:00
Agenus Shareholders Equity (Quarterly) : -221.22M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 6.068M |
| Amarin Corp. Plc | 449.41M |
| Vertex Pharmaceuticals, Inc. | 19.36B |
| Halozyme Therapeutics, Inc. | 219.64M |
| Protalix Biotherapeutics, Inc. | 67.23M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 186.46M |
| Total Liabilities (Quarterly) | 414.44M |
| Debt to Equity Ratio | -1.376 |
| Current Ratio | 0.3823 |
| Net Debt Paydown Yield | 19.72% |